See Graham's ranking
4.0
Intuitive Surgical Inc. operates in the healthcare sector, within the medical equipment and devices industry, and was founded in 1995 by Frederic Moll, Robert Younge, and John Freund.
Specializing in the development of robotic-assisted surgical technologies, the company is widely recognized for its Da Vinci Surgical System.
The system comprises three or four main components, depending on the configuration:
Surgeon Console: A control workstation where the surgeon operates, providing high-definition 3D visualization and intuitive control of surgical instruments.
Patient Cart: Positioned next to the patient, equipped with robotic arms that manipulate instruments and the endoscopic camera.
Vision Cart: A separate cart that houses the vision system, though in certain configurations the visualization component is integrated into the patient cart.
EndoWrist Instruments: Articulated surgical instruments designed to enable precise and flexible movements inside the patient’s body.
The company’s product portfolio includes robotic systems, surgical instrumentation, and advanced software solutions aimed at enhancing accuracy and efficiency in minimally invasive procedures.
Its technology enables surgeons to perform operations with greater control, reduced risk of complications, and faster recovery times for patients.
Clients include hospitals, clinics, and surgical centers that employ these solutions for procedures in urology, gynecology, general surgery, cardiology, and oncology.
Operations are global, with equipment distribution and customer support services across North America, Europe, Asia, and other strategic regions.
The business model encompasses the sale of surgical robots, long-term service contracts, continuous supply of disposable instruments, and ongoing technology upgrades.
Market conditions are influenced by medical-industry regulations, technological innovation, competitive dynamics in robotic surgery, and broader digitalization trends in healthcare. The company invests heavily in research and development to enhance its solutions and expand applications into new medical specialties.
With a workforce of approximately 8,000 employees, the company maintains research centers, manufacturing facilities, and commercial offices across several countries. Its production and distribution framework is structured to ensure consistent support for hospitals and surgical centers using its technologies.
History and Foundation of Intuitive Surgical Inc.
Intuitive Surgical Inc. was founded in 1995 in the United States by Frederic Moll, Robert Younge, and John Freund with the objective of developing advanced technologies for minimally invasive surgery. Since inception, the company has focused on innovation in surgical robotics, transforming how medical procedures are performed.
In its early years, efforts centered on research and development of a robotic-assisted surgical platform inspired by military technologies designed for remote medical procedures. A major milestone was achieved in 2000, when the company received FDA (Food and Drug Administration) clearance to commercially launch the Da Vinci Surgical System, becoming a pioneer in the field.
Adoption of the Da Vinci system expanded rapidly among hospitals and surgeons, driving the company’s global growth.
In 2000, Intuitive Surgical conducted its initial public offering (IPO) on the Nasdaq, raising capital to scale production and accelerate research initiatives. In subsequent years, the company enhanced its technology, introducing new iterations of the Da Vinci system featuring greater precision, improved visualization, and integrated artificial intelligence capabilities.
Between 2010 and 2020, the company solidified its leadership in the robotic surgery market, broadening its portfolio of products and services. In addition to its expansion in the hospital sector, Intuitive Surgical developed training and simulation programs to support surgeon proficiency.
In the period from 2020 to 2024, the company continued to innovate, exploring artificial intelligence and advanced automation to optimize surgical workflows.
Growing demand for minimally invasive procedures and increased requirements for medical precision strengthened its position as a leading reference in medical robotics.
Intuitive Surgical continues to invest in emerging technologies and strategic partnerships, supporting the evolution of robotics in medicine and expanding access to safer and more efficient treatment options worldwide.
Additional Information
The Company Intuitive Surgical Inc. (United States), is listed on Nasdaq with a market cap of $ 200.49 Billions, having an equity of $ 17.04 Billions.
With a total of 8.081 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.
In the last 12 months the Company had a revenue of $ 9.61 Billions, which generated a profit in the amount of $ 2.75 Billions.
As for its main indicators, the Company has a P/E ratio of 72.99, a P/BV ratio of 11.76 and in the last 12 months the Company did not pay dividends.
The Company is traded internationally through the ticker ISRG.
